News

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...
IN higher education, emphasis is largely placed on equipping students with future-ready skills, such as digital literacy, ...
A collection of videos, study abstracts, and other resources all focused on disparities in obesity. Obesity is independently ...
The global food system is under growing strain from rising population, food insecurity, and obesity. Since 1985, the world’s ...
Obesity is associated with financial hardship and food insecurity, according to a research letter published online June 24 in ...
Weight loss isn’t just cosmetic; it prevents chronic disease, saves money and improves mental and physical well-being.
Study shows people with high body fat are 78% more likely to die and three times more likely to die from heart disease, ...
The health ministry has initiated plans to reduce the price of stents, increasing the number of functional catheterisation labs (cath labs), and establishing Coronary Care Units (CCUs) in several hosp ...
GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and improved metabolic health. However, concerns about long-term safety, cost, and ...
More than 78% percent of employees in the US now have at least one chronic condition, an increase of 7% since 2021.